Macrophage Colony Stimulating Factor [CSF-1]

The Cytokine Handbook

Volumn , Issue , 2003, Pages 927-958

  Lotze, Michael T ^a   Hamilton, John A ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84942849763     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012689663-3/50044-2     Document Type: Chapter

References (312)

1. Abraham D., Podar K., Pacher M., et al. Raf-1-associated protein phosphatase 2A as a positive regulator of kinase activation. J. Biol. Chem. 2000, 275(29):22300-22304.
2. Aharinejad S., Abraham D., Paulus P., et al. Colonystimulating factor-1 antisense treatment suppresses growth of human tumor xenografts in mice. Cancer Res. 2002, 62:5317-5324.
3. Allen W.E., Jones G.E., Pollard J.W., et al. Rho, Rac and Cdc 42 regulate actin organization and cell adhesion in macrophages. J. Cell. Sci. 1997, 110(Pt 6):707-720.
4. Alonso G., Koegl M., Mazurenko N., Courtneidge S.A. Sequence requirements for binding, of Src family tyrosine kinases to activated growth factor receptors. J. Biol. Chem. 1995, 270(17):9840-9848.
5. Aziz N., Cherwinski H., McMahon M. Complementation of defective colony-stimulating factor 1 receptor signaling and mitogenesis by Raf and v-Src. Mol. Cell. Biol. 1999, 19(2):1101-1115.
6. Azizi S.A., Stokes D., Augelli B.J., et al. Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats-similarities to astrocyte grafts. Proc. Natl. Acad. Sci. USA 1998, 95:3908-3913.
7. Baccarini M., Sabatini D.M., App H., et al. Colony stimulating factor-1 (CSF-1) stimulates temperature dependent phosphorylation and activation of the RAF-1 proto-oncogene product. Embo J. 1990, 9(11):3649-3657.
8. Barone M.V., Courtneidge S.A. Myc but not Fos rescue of PDGF signaling block caused by kinase-inactive Src. Nature 1995, 378(6556):509-512.
9. Berg K.L., Carlberg K., Rohrschneider L.R., et al. The major SHP-1-binding, tyrosine-phosphorylated protein in macrophages is a member of the KIR/LIR family and an SHP-1 substrate. Oncogene 1998, 17(19):2535-2541.
10. Berg K.L., Siminovitch K.A., Stanley E.R. SHP-1 regulation of p62(DOK) tyrosine phosphorylation in macrophages. J. Biol. Chem. 1999, 274(50):35855-35865.
11. Bischoff J.R., Kirn D.H., Williams A., et al. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 1996, 274:373-376.
12. Blenis J. Signal transduction via the MAP kinases: proceed at your own RSK. Proc. Natl. Acad. Sci. USA 1993, 90(13):5889-5892.
13. Bortner D.M., Ulivi M., Roussel M.F., Ostrowski M.C. The carboxy-terminal catalytic domain of the GTPase-activating protein inhibits nuclear signal transduction and morphological transformation mediated by the CSF-1 receptor. Genes Dev. 1991, 5(10):1777-1785.
14. Borzillo G.V., Ashmun R.A., Sherr C.J. Macrophage lineage switching of murine early pre-B lymphoid cells expressing transduced fms genes. Mol. Cell. Biol. 1990, 10(6):2703-2714.
15. Bourette R.P., Arnaud S., Myles G.M., et al. Mona, a novel hematopoietic-specific adaptor interacting with the macrophage colony-stimulating factor receptor, is implicated in monocyte/macrophage development. EMBO J. 1998, 17:7273-7281.
16. Bourette R.P., De Sepulveda P., Arnaud S., et al. Suppressor of cytokine signaling 1 interacts with the macrophage colony-stimulating factor receptor and negatively regulates its proliferation signal. J. Biol. Chem. 2001, 276(25):22133-22139.
17. Bourette R.P., Myles G.M., Carlberg K., et al. Uncoupling of the proliferation and differentiation signals mediated by the murine macrophage colony-stimulating factor receptor expressed in myeloid FDC-P1 cells. Cell Growth Differ 1995, 6(6):631-645.
18. Bourette R.P., Myles G.M., Choi J.L., et al. Sequential activation of phosphatidylinositol 3-kinase and phospholipase C-gamma2 by the M-CSF receptor is necessary for differentiation signaling. Embo. J. 1997, 16(19):5880-5893.
19. Bourette R.P., Rohrschneider L.R. Early events in M-CSF receptor signaling. Growth Factors 2000, 17(3):155-166.
20. Bourgin C., Bourette R.P., Arnaud S., et al. Induced expression and association of the Mona/Gads adapter and Gab3 scaffolding protein during monocyte/macrophage differentiation. Mol. Cell. Biol. 2002, 22:3744-3756.
21. Branch D.R., Turner A.R., Guilbert L.J. Synergistic stimulation of macrophage proliferation by the monokines tumor necrosis factor-alpha and colony-stimulating factor 1. Blood 1989, 73(1):307-311.
22. Büscher D., Hipskind R.A., Krautwald S., et al. Ras-dependent and -independent pathways target the mitogen-activated protein kinase network in macrophages. Mol. Cell. Biol. 1995, 15(1):466-475.
23. Büscher D., Sbarba P.D., Hipskind R.A., et al. v-raf confers CSF-1 independent growth to a macrophage cell line and leads to immediate early gene expression without MAP-kinase activation. Oncogene 1993, 8(12):3323-3332.
24. Campbell I.K., Rich M.J., Bischof R.J., Hamilton J.A. The colony-stimulating factors and collagen-induced arthritis: exacerbation of disease by M-CSF and G-CSF and requirement for endogenous M-CSF. J. Leukoc. Biol. 2000, 68:144-150.
25. Carlberg K., Rohrschneider L. The effect of activating mutations on dimerization, tyrosine phosphorylation and internalization of the macrophage colony stimulating factor receptor. Mol. Biol. Cell. 1994, 5(1):81-95.
26. Carlberg K., Tapley P., Haystead C., Rohrschneider L. The role of kinase activity and the kinase insert region in ligand- induced internalization and degradation of the c-fms protein. Embo J. 1991, 10(4):877-883.
27. Cenci E., Bartocci A., Puccetti P., et al. Macrophage colony-stimulating factor in murine candidiasis: serum and tissue levels during infection and protective effect of exogenous administration. Infect. Immun. 1991, 59:868-872.
28. Chen H.E., Chang S., Trub T., Neel B.G. Regulation of colony-stimulating factor 1 receptor signaling by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol. Cell. Biol. 1996, 16(7):3685-3697.
29. Cheng M., Wang D., Roussel M.F. Expression of c-Myc in response to colony-stimulating factor-1 requires mitogen-activated protein kinase kinase-1. J. Biol. Chem. 1999, 274(10):6553-6558.
30. Choudhury G.G., Sylvia V.L., Sakaguchi A.Y. The kinase insert domain of colony stimulating factor-1 receptor is dispensable for CSF-1 induced phosphatidylcholine hydrolysis. FEBS Lett. 1991, 282(2):351-354.
31. Choudhury G.G., Sylvia V.L., Pfeifer A., et al. Human colony stimulating factor-1 receptor activates the C-raf-1 proto-oncogene kinase. Biochem. Biophys. Res. Commun. 1990, 172(1):154-159.
32. Choudhury G.G., Sylvia V.L., Wang L.-M., et al. Activation of a phosphatidylcholine-specific phospholipase C by colony stimulating factor 1 receptor requires tyrosine phosphorylation and a guanine nucleotide-binding protein. J. Biol. Chem. 1991, 266(34):23147-23151.
33. Choudhury G.G., Wang L.-M., Pierce J., et al. A mutational analysis of phosphatidylinositol-3-kinase activation by human colony-stimulating factor-1 receptor. J. Biol. Chem. 1991, 266(13):8068-8072.
34. Cocks B.G., Vairo G., Bodrug S.E., Hamilton J.A. Suppression of growth factor-induced CYL1 cyclin gene expression by antiproliferative agents. J. Biol. Chem. 1992, 267(17):12307-12310.
35. Cole D.J., Sanda M.G., Yang J.C., et al. Phase I trial of recombinant human macrophage colony-stimulating factor administered by continuous intravenous infusion in patients with metastatic cancer. J. Natl. Cancer Inst. 1994, 86:39-45.
36. Cooper M.H., Gregory S.H., Starzl T.E., Wing E.J. Rapamycin but not FK506 inhibits the proliferation of mononuclear phagocytes induced by colony-stimulating factors. Transplantation 1994, 57(3):433-439.
37. Corre I., Hermouet S. Regulation of colony-stimulating factor 1-induced proliferation by heterotrimeric Gi2 proteins. Blood 1995, 86(5):1776-1783.
38. Corre I., Baumann H., Hermouet S. Regulation by Gi2 proteins of v-fms-induced proliferation and transformation via Src-kinase and STAT3. Oncogene 1999, 18(46):6335-6342.
39. Cosman D., Wignall J., Anderson D., et al. Human macrophage colony stimulating factor (M-CSF): alternate RNA splicing generates three different proteins that are expressed on the cell surface and secreted. Behring Inst. Mitt. 1988, 15-26.
40. Courtneidge S.A., Dhand R., Pilat D., et al. Activation of Src family kinases by colony stimulating factor-1, and their association with its receptor. Embo. J. 1993, 12(3):943-950.
41. Coussens L., Van Beveren C., Smith D., et al. Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus. Nature 1986, 320(6059):277-280.
42. Cremer I., Dieu-Nosjean M.C., Marechal S., et al. Long-lived immature dendritic cells mediated by TRANCE-RANK interaction. Blood 2002, 15(100):3646-3655. (10).
43. Csar X.F., Wilson N.J., McMahon K.A., et al. Proteomic analysis of macrophage differentiation. p46/52(Shc) Tyrosine phosphorylation is required for CSF-1-mediated macrophage differentiation. J. Biol. Chem. 2001, 276(28):26211-26217.
44. Dai X.M., Ryan G.R., Hapel A.J., et al. Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood 2002, 99(1):111-120.
45. Dan Q., Trinh H., Williams C.C., et al. Dexamethasone increases the expression of membrane macrophage colony stimulating factor from retrovirally transduced tumor cells expressing macrophage colony stimulating factor. Int. Immunopharmacol. 2001, 1:737-748.
46. Davis J.N., Rock C.O., Cheng M., et al. Complementation of growth factor receptor-dependent mitogenic signaling by a truncated type I phosphatidylinositol 4-phosphate 5-kinase. Mol. Cell. Biol. 1997, 17(12):7398-7406.
47. Deng P., Wang Y.L., Haga Y., Pattengale P.K. Multiple factors determine the selection of the ectodomain cleavage site of human cell surface macrophage colony-stimulating factor. Biochemistry 1998, 37:17898-17904.
48. Deng P., Wang Y.L., Shahbazian V.L., Pattengale P.K. Biological characterization of uncleavable plasma membrane-anchored human macrophage colony-stimulating factor. Biochem. Biophys. Res. Commun. 2000, 276:304-311.
49. DeNichilo M.O., Burns G.F. Granulocyte-macrophage and macrophage colony-stimulating factors differentially regulated alpha v integrin expression on cultured human macrophages. Proc. Natl Acad. Sci. USA 1993, 90(6):2517-2521.
50. Dey A., She H., Kim L., et al. Colony-stimulating factor-1 receptor utilizes multiple signaling pathways to induce cyclin D2 expression. Mol. Biol. Cell. 2000, 11(11):3835-3848.
51. Dorsch M., Hock H., Kunzendorf U., et al. Macrophage colony-stimulating factor gene transfer into tumor cells induces macrophage infiltration but not tumor suppression. Eur. J. Immunol. 1993, 23:186-190.
52. Downing J.R., Margolis B.L., Zilberstein A., et al. Phospholipase C-γ, a substrate for PDGF receptor kinase, is not phosphorylated on tyrosine during the mitogenic response to CSF-1. Embo J. 1989, 8(11):3345-3350.
53. Downing J.R., Shurtleff S.A., Sheer C.J. Peptide antisera to human colony-stimulating factor 1 receptor detect ligand-induced conformational changes and a binding site for phosphatidylinositol 3-kinase. Mol. Cell. Biol. 1991, 11(5):2489-2495.
54. Egan S.E., Weinberg R.A. The pathway to signal achievement. Nature 1993, 365:781-783.
55. Fan X., Biskobing D.M., Fan D., et al. Macrophage colony stimulating factor down-regulates MCSF-receptor expression and entry of progenitors into the osteoclast lineage. J. Bone Miner. Res. 1997, 12:1387-1395.
56. Fischer H.G., Bielinsky A.K. Antigen presentation function of brain-derived dendriform cells depends on astrocyte help. Int. Immunol. 1999, 11:1265-1274.
57. Fischer H.G., Reichmann G. Brain dendritic cells and macrophages/microglia in central nervous system inflammation. J. Immunol. 2001, 166:2717-2726.
58. Foltz I.N., Lee J.C., Young P.R., Schrader J.W. Hemopoietic growth factors with the exception of interleukin-4 activate the p38 mitogen-activated protein kinase pathway. J. Biol. Chem. 1997, 272(6):3296-3301.
59. Fowles L.F., Martin M.L., Nelsen L., et al. Persistent activation of mitogen-activated protein kinases p42 and p44 and ets-2 phosphorylation in response to colony-stimulating factor 1/c-fms signaling. Mol. Cell. Biol. 1998, 18(9):5148-5156.
60. Friedman A.D. Transcriptional regulation of granulocyte and monocyte development. Oncogene 2002, 21:3377-3390.
61. Gadducci A., Ferdeghini M., Castellani C., et al. Serum macrophage colony-stimulating factor (M-CSF) levels in patients with epithelial ovarian cancer. Gynecol. Oncol. 1998, 70:111-114.
62. Gibbs J.B., Marshall M.S., Scolnick E.M., et al. Modulation of guanine nucleotides bound to Ras in NIH3T3 cells by oncogenes, growth factors, and the GTPase activating protein (GAP). J. Biol. Chem. 1990, 265(33):20437-20442.
63. Glover H.R., Baker D.A., Celetti A., Dibb N.J. Selection of activating mutations of c-fms in FDC-P1 cells. Oncogene 1995, 11(7):1347-1356.
64. Grey A., Chen Y., Paliwal I., et al. Evidence for a functional association between phosphatidylinositol 3-kinase and c-src in the spreading response of osteoclasts to colony-stimulating factor-1. Endocrinology 2000, 141(6):2129-2138.
65. Grigoriadis A.E., Wang Z.Q., Cecchini M.G., et al. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 1994, 266(5184):443-448.
66. Gruber M.F., Weih K.A., Boone E.J., et al. Endogenous macrophage CSF production is associated with viral replication in HIV-1-infected human monocyte-derived macrophages. J. Immunol. 1995, 154:5528-5535.
67. Guilbert L.J., Stanley E.R. The interaction of 125I-colony-stimulating factor-1 with bone marrow-derived macrophages. J. Biol. Chem. 1986, 261(9):4024-4032.
68. Hamilton J.A. Colony stimulating factors, cytokines and monocyte-macrophages-some controversies. Immunol. Today 1993, 14(1):18-24.
69. Hamilton J.A., Byrne R., Whitty G. Particulate adjuvants can induce macrophage survival, DNA synthesis, and a synergistic proliferative response to GM-CSF and CSF-1. J. Leukoc. Biol. 2000, 67:226-232.
70. Hamilton J.A., Byrne R., Jessup W., et al. Comparison of macrophage responses to oxidized low-density lipoprotein and macrophage colony-stimulating factor (M-CSF or CSF-1). Biochem. J. 2001, 354:179-187.
71. Hamilton J.A., Byrne R., Whitty G., et al. Effects of wortmannin and rapamycin on CSF-1-mediated responses in macrophages. Int. J. Biochem. Cell. Biol. 1998, 30(2):271-283.
72. Hamilton J.A., Chan J., Byrne R.J., et al. MRL/lpr and MRL+/+ macrophage DNA synthesis in the absence and the presence of colony-stimulating factor-1 and granulocyte-macrophage colony-stimulating factor. J. Immunol. 1998, 161:6802-6811.
73. Hamilton J.A., Myers D., Jessup W., et al. Oxidized LDL can induce macrophage survival, DNA synthesis, and enhanced proliferative response to CSF-1 and GM-CSF. Arterioscler. Thromb. Vasc. Biol. 1999, 19:98-105.
74. Hamilton J.A., Vairo G., Cocks B.G. Inhibition of S-phase progression in macrophages is linked to G1/S-phase suppression of DNA synthesis genes. J. Immunol. 1992, 148(12):4028-4035.
75. Hamilton J.A., Vairo G., Knight K.R., Cocks B.G. Activation and proliferation signals in murine macrophages. Biochemical signals controlling the regulation of macrophage urokinase-type plasminogen activator activity by colony-stimulating factors and other agents. Blood 1991, 77(3):616-627.
76. Hamilton J.A., Veis N., Bordun A.M., et al. Activation and proliferation signals in murine macrophages: relationships among c-fos and c-myc expression, phosphoinositide hydrolysis, superoxide formation, and DNA synthesis. J. Cell. Physiol. 1989, 141(3):618-626.
77. Hamilton J.A., Whitty G., White A.R., et al. Alzheimer's disease amyloid beta and prion protein amyloidogenic peptides promote macrophage survival, DNA synthesis and enhanced proliferative response to CSF-1 (M-CSF). Brain Res. 2002, 940:49-54.
78. Hamilton J.A., Whitty G.A., Kola I., Hertzog P.J. Endogenous IFN-alpha beta suppresses colony-stimulating factor (CSF)-1-stimulated macrophage DNA synthesis and mediates inhibitory effects of lipopolysaccharide and TNF-alpha. J. Immunol. 1996, 156(7):2553-2557.
79. Hamilton J.A., Whitty G.A., Stanton H., Meager A. Effects of macrophage-colony stimulating factor on human monocytes: induction of expression of urokinase-type plasminogen activator, but not of secreted prostaglandin E2, interleukin-6, interleukin-1, or tumor necrosis factor-alpha. J. Leukoc. Biol. 1993, 53(6):707-714.
80. Hartmann T., Seuwen K., Roussel M.J., et al. Functional expression of the human receptor for colony-stimulating factor 1 (CSF-1) in hamster fibroblasts: CSF-1 stimulates Na+/H+ exchange and DNA-synthesis in the absence of phosphoinositide breakdown. Growth Factors 1990, 2(4):289-300.
81. Hatch W.C., Ganju R.K., Hiregowdara D., et al. The related adhesion focal tyrosine kinase (RAFTK) is tyrosine phosphorylated and participates in colony-stimulating factor-1/macrophage colony-stimulating factor signaling in monocyte-macrophage. Blood 1998, 91(10):3967-3973.
82. Hattersley G., Dorey E., Horton M.A., Chambers T.J. Human macrophage colony-stimulating factor inhibits bone resorption by osteoclasts disaggregated from rat bone. J. Cell. Physiol. 1988, 137:199-203.
83. Hayashi T., Kaneda T., Toyama Y., et al. Regulation of receptor activator of NF-kappa B ligand-induced osteoclastogenesis by endogenous interferon-beta (INF-beta) and suppressors of cytokine signaling (SOCS). The possible counteracting role of SOCSs- in IFN-beta-inhibited osteoclast formation. J. Biol. Chem. 2002, 277:27880-27886.
84. Haynes D.R., Crotti T.N., Potter A.E., et al. The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis. J. Bone Joint Surg. Br. 2001, 83:902-911.
85. He Y.X., Hewlett E., Temeles D., Quesenberry P. Inhibition of interleukin 3 and colony-stimulating factor 1-stimulated marrow cell proliferation by pertusis toxin. Blood 1988, 71(5):1187-1195.
86. Heidaran M.A., Molloy C.J., Pangelinan M., et al. Activation of the colony-stimulating factor 1 receptor leads to the rapid tyrosine phosphorylation of GTPase-activating protein and activation of cellular p21ras. Oncogene 1992, 7(1):147-152.
87. Hipskind R.A., Büscher D., Nordheim A., Baccarini M. Ras/MAP kinase-dependent and -independent signaling pathways target distinct ternary complex factors. Genes Dev. 1994, 8(15):1803-1816.
88. Hirayama T., Danks L., Sabokbar A., Athanasou N.A. Osteoclast formation and activity in the pathogenesis of osteoporosis in rheumatoid arthritis. Rheumatology (Oxford) 2002, 41:1232-1239.
89. Hirayama T., Sabokbar A., Athanasou N.A. Effect of corticosteroids on human osteoclast formation and activity. J. Endocrinol. 2002, 175:155-163.
90. Hock H., Dorsch M., Kunzendorf U., et al. Vaccinations with tumor cells genetically engineered to produce different cytokines: effectivity not superior to a classical adjuvant. Cancer Res. 1993, 53:714-716.
91. Holloway W.R., Collier F.M., Aitken C.J., et al. Leptin inhibits osteoclast generation. J. Bone Miner. Res. 2002, 17:200-209.
92. Hubel K., Dale D.C., Liles W.C. Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma. J. Infect. Dis. 2002, 185:1490-1501.
93. Hume D.A., Denkins Y. The deleterious effect of macrophage colony-stimulating factor (CSF-1) on the pathology of experimental candidiasis in mice. Lymphokine Cytokine Res. 1992, 11:95-98.
94. Husson H., Mograbi B., Schmid-Antomarchi H., et al. CSF-1 stimulation induces the formation of a multiprotein complex including CSF-1 receptor, c-Cbl, PI 3-kinase, Crk-II and Grb2. Oncogene 1997, 14(19):2331-2338.
95. Igarashi H., Hatake K., Shiraishi H., et al. Elevated serum levels of macrophage colony-stimulating factor in patients with Kawasaki disease complicated by cardiac lesions. Clin. Exp. Rheumatol. 2001, 19:751-756.
96. Imamura K., Kufe D. Colony-stimulating factor 1-induced Na+ influx into human monocytes involves activation of a pertussis toxin-sensitive GTP-binding protein. J. Biol. Chem. 1988, 263(28):14093-14098.
97. Imamura K., Dianoux A., Nakamura T., Kufe D. Colony-stimulating factor 1 activates protein kinase C in human monocytes. Embo J. 1990, 9(8):2423-2429.
98. Insogna K., Tanaka S., Neff L., et al. Role of c-Src in cellular events associated with colony-stimulating factor-1-induced spreading in osteoclasts. Mol. Reprod. Dev. 1997, 46(1):104-108.
99. Itoh Y., Okanoue T., Ohnishi N., et al. Serum levels of soluble tumor necrosis factor receptors and effects of interferon therapy in patients with chronic hepatitis C virus infection. Am. J. Gastroenterol. 1999, 94:1332-1340.
100. Itoh Y., Okanoue T., Ohnishi N., et al. Hepatic damage induced by transcatheter arterial chemo-embolization elevates serum concentrations of macrophage-colony stimulating factor. Liver 1999, 19:97-103.
101. Jackowski S., Rettenmier C.W., Rock C.O. Prostaglandin E2 inhibition of growth in a colony-stimulating factor 1-dependent macrophage cell line. J. Biol. Chem. 1990, 265(12):6611-6616.
102. Jackowski S., Rettenmier C.W., Sherr C.J., Rock C.O. A guanine nucleotide-dependent phosphatidyli-nositol 4,5-diphosphate phospholipase C in cells transformed by the v-fms and v-fes oncogenes. J. Biol. Chem. 1986, 261(11):4978-4985.
103. Jakubowski A.A., Bajorin D.F., Templeton M.A., et al. Phase I study of continuous-infusion recombinant macrophage colony-stimulating factor in patients with metastatic melanoma. Clin. Cancer Res. 1996, 2:295-302.
104. Jaworowski A., Argyriou S., Yusoff P., Hamilton J.A. Phospholipase D is activated by phorbol ester but not CSF-1 in murine bone marrow-derived macrophages. Biochem. Biophys. Res. Commun. 1994, 201(2):733-739.
105. Jaworowski A., Christy E., Yusoff P., et al. Differences in the kinetics of activation of protein kinases and extra-cellular signal-related protein kinase 1 in colory-stimulating factor 1-stimulated and lipopolysaccharide-stimulated macrophages. Biochem. J. 1996, 320(Pt 3):1011-1016.
106. Jaworowski A., Wilson N.J., Christy E., et al. Roles of the mitogen-activated protein kinase family in macrophage responses to colony stimulating factor-1 addition and withdrawal. J. Biol. Chem. 1999, 274(21):15127-15133.
107. Jewell A.P., Yong K.L., Worman C.P., et al. Serum macrophage colony-stimulatingfactor (M-CSF) levels correlate with clinical response to interferon-alpha in patients with early-stage B-CLL. Br. J. Haematol. 1999, 86:441-443.
108. Jin D.I., Jameson S.B., Reddy M.A., et al. Alterations in differentiation and behavior of monocytic phagocytes in transgenic mice that express dominant suppressors of ras signaling. Mol. Cell. Biol. 1995, 15(2):693-703.
109. Joly M., Kazlauskas A., Corvera S. Phosphatidylinositol 3-kinase activity is required at a postendocytic step in platelet-derived growth factor receptor trafficking. J. Biol. Chem. 1995, 270(22):13225-13230.
110. Joos H., Trouliaris S., Helftenbein G., et al. Tyrosine phosphorylation of the juxtamembrane domain of the v-Fms oncogene product is required for its association with a 55-kDa protein. J. Biol. Chem. 1996, 271(40):24476-24481.
111. Josien R., Wong B.R., Li H.L., et al. TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells. J. Immunol. 1999, 162:2562-2568.
112. Kanagasundaram V., Christy E., Hamilton J.A., Jaworowski A. Different pathways of colony-stimulating factor 1 degradation in macrophage populations revealed by wortmannin sensitivity. Biochem. J. 1998, 330(Pt 1):197-202.
113. Kanagasundaram V., Jaworowski A., Byrne R., et al. Separation and characterization of the activated pool of colony-stimulating factor 1 receptor forming distinct multimeric complexes with signalling molecules in macrophages. Mol. Cell. Biol. 1999, 19(6):4079-4092.
114. Kanagasundaram V., Jaworowski A., Hamilton J.A. Association between phosphatidylinositol-3 kinase, Cbl and other tyrosine phosphorylated proteins in colony-stimulating factor-1-stimulated macrophages. Biochem. J. 1996, 320(Pt 1):69-77.
115. Kanekiyo M., Itoh N., Kawasaki A., et al. Metallothionein is required for zinc-induced expression of the macrophage colony stimulating factor gene. J. Cell Biochem. 2002, 86:145-153.
116. Kascinski B. Expression of CSF-1 and its receptor CSF-1R in non-hematopoietic neoplasms. Cancer Treat. Res. 2002, 107:285-292.
117. Kato J.Y., Matsuoka M., Polyak K., et al. Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation. Cell 1994, 79(3):487-496.
118. Katsumata N., Eguchi K., Fukuda M., et al. Serum levels of cytokines in patients with untreated primary lung cancer. Clin. Cancer Res. 1996, 2:553-559.
119. Kawasaki E.S., Ladner M.B. Molecular biology of macrophage colony-stimulating factor. Immunol Ser. 1990, 49:155-176.
120. Kawasaki E.S., Ladner M.B., Wang A.M., et al. Molecular cloning of a complementary DNA encoding human macrophage-specific colony-stimulating factor (CSF-1). Science 1985, 230:291-296.
121. Keith J.C., Pijnenborg R., Luyten C., et al. Maternal serum levels of macrophage colony-stimulating factor are associated with adverse pregnancy outcome. Eur. J. Obstet. Gynecol. Reprod. Biol. 2000, 89:19-25.
122. Kelley T.W., Graham M.M., Doseff A.I., et al. Macrophage colony-stimulating factor promotes cell survival through Akt/protein kinase B. J. Biol. Chem. 1999, 274(37):26393-26398.
123. Kermanac'h N.S., Bessis N., Cohen-Solal M., et al. Osteoprotegerin and inflammation. Eur. Cytokine Netw. 2002, 13:144-153.
124. Kharbanda S., Saleem A., Yuan Z., et al. Stimulation of human monocytes with macrophage colony-stimulating factor induces a Grb2-mediated association of the focal adhesion kinase pp125FAK and dynamin. Proc. Natl. Acad. Sci. USA 1995, 92(13):6132-6136.
125. Kim N., Takami M., Rho J., et al. A novel member of the leukocyte receptor complex regulates osteoclast differentiation. J. Exp. Med. 2002, 195:201-209.
126. Kimura f., Suzu S., Nakamura Y., et al. Structural analysis of proteoglycan macrophage colony-stimulating factor. J. Biol. Chem. 1994, 269:19751-19756.
127. Kojima H., Nemoto A., Uemura T., et al. rDrak1, a novel kinase related to apoptosis, is strongly expressed in active osteoclasts and induces apoptosis. J. Biol. Chem. 2001, 276:19238-19243.
128. Kondo H., Guo J., Bringhurst F.R. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells. J. Bone Miner. Res. 2002, 17:1667-1679.
129. Koths K. Structure-function studies on human macrophage colony-stimulating factor (M-CSF). Mol. Reprod. Dev. 1997, 46:31-37.
130. Krautwald S., Büscher D., Dent P., et al. Suppression of growth factor-mediated MAP kinase activation by v-raf in macrophages: a putative role for the MKP-1 phosphatase. Oncogene 1995, 10(6):1187-1192.
131. Krautwald S., Büscher D., Kummer V., et al. Involvement of the protein tyrosine phosphatase SHP-1 in Ras-mediated activation of the mitogen-activated protein kinase pathway. Mol. Cell Biol. 1996, 16(11):5955-5963.
132. Kudo O., Fujikawa Y., Itonaga I., et al. Proinflammatory cytokine (TNFalpha/IL-1alpha) induction of human osteoclast formation. J. Pathol. 2002, 198:220-227.
133. Kudo O., Sabokbar A., Pocock A., et al. Isolation of Human Osteoclasts Formed In vitro: Hormonal Effects on the Bone-Resorbing Activity of Human Osteoclasts. Calcified Tissue International. 2002.
134. Kuhara T., Uchida K., Yamaguchi H. Therapeutic efficacy of human macrophage colony-stimulating factor, used alone and in combination with antifungal agents, in mice with systemic Candida albicans infection. Antimicrob. Agents Chemother. 2000, 44:19-23.
135. Kullberg B.J., 't Wout J.W., Poell R.J., van Furth R. Combined effect of fluconazole and recombinant human interleukin-1 on systemic candidiasis in neutropenic mice. Antimicrob. Agents Chemother. 1992, 36:1225-1229.
136. Kutza J., Crim L., Feldman S., et al. Macrophage colony-stimulating factor antagonists inhibit replication of HIV-1 in human macrophages. J. Immunol. 2000, 164:4955-4960.
137. Kutza J., Fields K., Grimm T.A., Clouse K.A. Inhibition of HIV replication and macrophage colony-stimulating factor production in human macrophages by antiretroviral agents. AIDS Res. Hum. Retroviruses 2002, 18:619-625.
138. Ladner M.B., Martin G.A., Noble J.A., et al. Human CSF-1: gene structure and alternative splicing of mRNA precursors. EMBO J. 1987, 6(9):2693-2698.
139. Laguens G., Coronato S., Laguens R., et al. Human regional lymph nodes draining cancer exhibit a profound dendritic cell depletion as comparing to those from patients without malignancies. Immunol. Lett. 2002, 84(3):159-162.
140. Langer S.J., Bortner D.M., Roussel M.F., et al. Mitogenic signaling by colony-stimulating factor 1 and ras is supprressed by the ets-2 DNA-binding domain and restored by myc overexpression. Mol. Cell. Biol. 1992, 12(12):5355-5362.
141. Lean J.M., Fuller K., Chambers T.J. FLT3 ligand can substitute for macrophage colony-stimulating factor in support of osteoclast differentiation and function. Blood 2001, 98:2707-2713.
142. Lee A.W.-M. Signal transduction by the colony-stimulating factor-1 receptor; comparison to other receptor tyrosine kinases. Curr. Top. Cell. Regul. 1991, 32:73-181.
143. Lee J.C., Laydon J.T., McDonnell P.C., et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994, 372(6508):739-746.
144. Lee A.W., States D.J. Both src-dependent and-independent mechanisms mediate phosphatidylinositol 3-kinase regulation of colony-stimulating factor 1-activated mitogen-activated protein kinases in myeloid progenitors. Mol. Cell. Biol. 2000, 20(18):6779-6798.
145. Lee P.S., Wang Y., Dominguez M.G., et al. The Cbl protooncoprotein stimulates CSF-1 receptor multiubiquitination and endocytosis, and attenuates macrophage proliferation. Embo J. 1999, 18(13):3616-3628.
146. Li G., Song Y.H., Wu K.F., et al. Clone and expression of mutant M-CSF and its receptor from human leukemic cell line J6-1. Leuk. Res. 2002, 26:377-382.
147. Li W., Stanley E.R. Role of dimerization and modification of the CSF-1 receptor in its activation and internalization during the CSF-1 response. Embo J. 1991, 10(2):277-288.
148. Lioubin M.N., Algate P.A., Tsai S., et al. p150Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity. Genes Dev. 1996, 10(9):1084-1095.
149. Lioubin M.N., Myles G.M., Carlberg K., et al. Shc, Grb2, Sos1, and a 150-kilodalton tyrosine-phosphorylated protein form complexes with Fms in hematopoietic cells. Mol. Cell. Biol. 1994, 14(9):5682-5691.
150. Liu Y., Jenkins B., Shin J.L., et al. Scaffolding protein Gab2 mediates differentiation signaling downstream of Fms receptor tyrosine kinase. Mol. Cell. Biol. 2001, 21(9):3047-3056.
151. Loudovaris M., Hansen M., Suen Y., et al. Differential effects of autologous serum on CD34(+) or monocyte-derived dendritic cells. J. Hematother. Stem Cell. Res. 2001, 10(4):569-578.
152. Luft T., Jefford M., Luetjens P., et al. IL-1 beta enhances CD40 ligand-mediated cytokine secretion by human dendritic cells (DC): a mechanism for T cell-independent DC activation. J. Immunol. 2002, 168(2):713-722.
153. Mackensen A., Krause T., Blum U., et al. Homing of intravenously and intralymphatically injected human dendritic cells generated in vitro from CD34+ hematopoietic progenitor cells. Cancer Immunol. Immunother. 1999, 48:118-122.
154. Mancini A., Koch A., Wilms R., et al. c-Cbl associates directly with the C-terminal tail of the receptor for the macrophage colony-stimulating factor, c-Fms, and down-modulates this receptor but not the viral oncogene v-Fms. J. Biol. Chem. 2002, 277(17):14635-14640.
155. Manger R., Najita L., Nichols E.J., et al. Cell surface expression of the McDonough strain of feline sarcoma virus fms gene product (gp 140fms). Cell 1984, 39(2 Pt 1):327-337.
156. Margolis B., Hu P., Katzav S., et al. Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs. Nature 1992, 356(6364):71-74.
157. Marks D.C., Csar X.E., Wilson N.J., et al. Expression of a Y559F mutant CSF-1 receptor in MI myeloid cells: a role for Src kinases in CSF-1 receptor-mediated differentiation. Mol. Cell. Biol. Res. Commun. 1999, 1(2):144-152.
158. Massey H.M., Scopes J., Horton M.A., Flanagan A.M. Transforming growth factor-betal (TGF-beta) stimulates the osteoclast-forming potential of peripheral blood hematopoietic precursors in a lymphocyte-rich microenvironment. Bone 2001, 28:577-582.
159. Matsushime H., Ewen M.E., Strom D.K., et al. Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins. Cell 1992, 71(2):323-334.
160. Matsushime H., Roussel M.F., Ashmun R.A., Sherr C.J. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 1991, 65(4):701-713.
161. McCoy K.L., Nielson K., Clagett J. Spontaneous production of colony-stimulating activity by splenic Mac-1 antigen-positive cells from autoimmune motheaten mice. J. Immunol. 1984, 132(1):272-276.
162. McGynn H., Baker A.H., Padua R.A. Biological consequences of a point mutation at codon 969 of the FMS gene. Leuk Res. 1998, 22(4):365-372.
163. McMahon K.A., Wilson N.J., Marks D.C., et al. Colony-stimulating factor-1 (CSF-1) receptor-mediated macrophage differentiation in myeloid cells: a role for tyrosine 559-dependent protein phosphatase 2A (PP2A) activity. Biochem. J. 2001, 358(Pt 2):431-436.
164. Metcalf D. Molecular control of granulocyte and macrophage production. Prog. Clin. Biol. Res. 1985, 191:323-337.
165. Minasian L.M., Yao T.J., Steffens T.A., et al. A phase I study of anti-GD3 ganglioside monoclonal antibody R24 and recombinant human macrophage-colony stimulating factor in patients with metastatic melanoma. Cancer 1995, 75:2251-2257.
166. Miyamoto T., Ohneda O., Arai F., et al. Bifurcation of osteoclasts and dendritic cells from common progenitors. Blood 2001, 98:2544-2554.
167. Moradi M.M., Carson L.F., Weinberg B., et al. Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer. Cancer 1993, 72:2433-2440.
168. Mori S., Claesson-Welsh L., Okuyama Y., Saito Y. Ligand-induced polyubiquitination of receptor tyrosine kinases. Biochem. Biophys. Res. Commun. 1995, 213(1):32-39.
169. Morley G.M., Uden M., Gullick W.J., et al. Cell specific transformation by c-fms activating loop mutations is attributable to constitutive receptor degradation. Oncogene 1999, 18(20):3076-3084.
170. Munn D.H., Cheung N.K. Antibody-dependent antitumor cytotoxicity by human monocytes cultured with recombinant macrophage colony-stimulating factor. Induction of efficient antibody-mediated antitumor cytotoxicity not detected by isotope release assays. J. Exp. Med. 1989, 170:511-526.
171. Munn D.H., Bree A.G., Beall A.C., et al. Recombinant human macrophage colony-stimulating factor in non-human primates: selective expansion of a CD16+ monocyte subset with phenotypic similarity to primate natural killer cells. Blood 1996, 88:1215-1224.
172. Murray J., Wilson L., Kellie S. Phosphatidylinositol-3' kinase-dependent vesicle formation in macrophages in response to macrophage colony stimulating factor. J. Cell. Sci. 2000, 113(Pt 2):337-348.
173. Murray J.T., Craggs G., Wilson L., et al. Mechanism of phosphatidylinositol 3-kinase-dependent increases in BAC1.2F5 macrophage-like cell density in response to M-CSF: phosphatidylinositol 3-kinase inhibitors increase the rate of apoptosis rather than inhibit DNA synthesis. Inflamm. Res. 2000, 49(11):610-618.
174. Myles G.M., Brandt C.S., Carlberg K., Rohrschneider L.R. Tyrosine 569 in the c-Fms juxtamembrane domain is essential for kinase activity and macrophage colony-stimulating factor-dependent internalization. Mol. Cell. Biol. 1994, 14(7):4843-4854.
175. Nakamura I., Lipfert L., Rodan G.A., et al. Convergence of alpha(v)beta(3) integrin- and macrophage colony stimulating factor-mediated signals on phospholipase Cgamma in prefusion osteoclasts. J. Cell. Biol. 2001, 152(2):361-373.
176. Nakamura M., Merchav S., Carter A., et al. Expression of a novel 3.5-kb macrophage colony-stimulating factor transcript in human myeloma cells. J. Immunol. 1989, 143:3543-3547.
177. Nakamura T., Lin L.-L., Kharbanda S., et al. Macrophage colony stimulating factor activates phosphatidylcholine hydrolysis by cytoplasmic phospholipase A2. Embo J. 1992, 11(13):4917-4922.
178. Nemunaitis J. Use of macrophage colony-stimulating factor in the treatment of fungal infections. Clin. Infect. Dis. 1998, 26:1279-1281.
179. Nemunaitis J., Meyers J.D., Buckner C.D., et al. Phase I trial of recombinant human macrophage colony-stimulating factor in patients with invasive fungal infections. Blood 1991, 78:907-913.
180. Nevins J.R. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 1992, 258(5081):424-429.
181. Nitta K., Akiba T., Kawashima A., et al. Serum levels of macrophage colony-stimulating factor and aortic calcification in hemodialysis patients. Am. J. Nephrol. 2001, 21:465-470.
182. Novak U., Harpur A.G., Paradiso L., et al. Colony-stimulating factor 1-induced STAT1 and STAT3 activation is accompanied by phosphorylation of Tyk2 in macrophages and Tyk2 and JAK1 in fibroblasts. Blood 1995, 86(8):2948-2956.
183. Novak U., Nice E., Hamilton J.A., Paradiso L. Requirement for Y706 of the murine (or Y708 of the human) CSF-1 receptor for STAT1 activation in response to CSF-1. Oncogene 1996, 13(12):2607-2613.
184. Ohtsuka M., Roussel M.F., Sherr C.J., Downing J.R. Ligand-induced phosphorylation of the colony-stimulating factor 1 receptor can occur through an inter-molecular reaction that triggers receptor down modulation. Mol. Cell. Biol. 1990, 10(4):1664-1671.
185. Ohtsuki T., Hatake K., Suzu S., et al. Immuno-histochemical identification of proteoglycan form of macrophage colony-stimulating factor on bone surface. Calcif. Tissue Int. 1995, 57:213-217.
186. Ohtsuki T., Ikeda M., Hatake K., et al. Quantitative analysis of the two macrophage colony-stimulating factor mRNA expressed in a human stromal cell line by reverse transcription-polymerase chain reaction (RT-PCR). Biochim. Biophys. Acta 1994, 1222:141-146.
187. Osborne J.M., den Elzen N., Lichanska A.M., et al. Murine DEP-1, a receptor protein tyrosine phosphatase, is expressed in macrophages and is regulated by CSF-1 and LPS. J. Leukoc. Biol. 1998, 64(5):692-701.
188. Ozaki S., Matsushita T., Ide M., et al. Macrophage colony-stimulating factor-producing malignant histiocytosis. Br. J. Haematol. 1995, 90:453-456.
189. Pandit J., Bohm A., Jancarik J., et al. Three-dimensional structure of dimeric human recombinant macrophage colony-stimulating factor. Science 1992, 258:1358-1362.
190. Perry V.H. A revised view of the central nervous system microenvironment and major histocompatibility complex class II antigen presentation. [Review] [74 refs]. J. Neuroimmunol. 1998, 90:113-121.
191. Pixley F.J., Lee P.S., Condeelis J.S., et al. Protein tyrosine phosphatase phi regulates paxillin tyrosine phosphorylation and mediates colony-stimulating factor 1-induced morphological changes in macrophages. Mol. Cell. Biol. 2001, 21(5):1795-1809.
192. Pogue-Geile K., Sakakeeny M.A., Panza J.L., et al. Cloning and expression of unique murine macrophage colony-stimulating factor transcripts. Blood 1995, 85:3478-3486.
193. Price L.K., Choi H.U., Rosenberg L., Stanley E.R. The predominant from of secreted colony stimulating factor-1 is a proteoglycan. J. Biol. Chem. 1992, 267:2190-2199.
194. Puri J., Pierce J.H., et al. Selective inhibition of PGE2 production in cells transfected with c-fms encoded CSF-1 receptor genes by the tyrosine kinase inhibitor, ST638. Agents Actions 1991, 33(3-4):314-317.
195. Qi C.F., Nieroda C., De Filippi R., et al. Macrophage colony-stimulating factor enhancement of antibody-dependent cellular cytotoxicity against human colon carcinoma cells. immunol. Lett. 1995, 47:15-24.
196. Qiu Z.H., Gijon M.A., de Carvalho M.S., et al. The role of calcium and phosphorylation of cytosolic phospholipase A2 in regulating arachindonic acid release in macrophages. J. Biol. Chem. 1998, 273(14):8203-8211.
197. Quinn J.M., Whitty G.A., Byrne R.J., et al. The generation of highly enriched osteoclast-lineage cell populations. Bone 2002, 30:164-170.
198. Quinn J.M., Whitty G.A., Byrne R.J., et al. The generation of highly enriched osteoclast-lineage cell populations. Bone 2002, 30:164-170.
199. Rajavashisth T.B., Eng R., Shadduck R.K., et al. Cloning and tissue-specific expression of mouse macrophage colony-stimulating factor mRNA. Proc. Natl. Acad. Sci. USA 1987, 84:1157-1161.
200. Ralph P., Warren M.K., Nakoinz I., et al. Biological properties and molecular biology of the human macrophage growth factor, CSF-1. Immunobiology 1986, 172:194-204.
201. Re F., Belyanskaya S.L., Riese R.J., et al. Granulocyte-macrophage colony-stimulating factor induces an expression program in neonatal microglia that primes them for antigen presentation. J. Immunol. 2002, 169:2264-2273.
202. Reddy S.M., Hsiao K.H., Abernethy V.E., et al. Phagocytosis of apoptotic cells by macrophages induces novel signaling events leading to cytokine-independent survival and inhibition of proliferation: activation of Akt and inhibition of extracellular signal-regulated kinases 1 and 2. J. Immunol. 2002, 169:702-713.
203. Redman B.G., Flaherty L., Chou T.H., et al. Phase I trial of recombinant macrophage colony-stimulating factor by rapid intravenous infusion in patients with cancer. J. Immunother. 1992, 12:50-54.
204. Reedijk M., Liu X., Pawson T. Interactions of phosphatidylinositol kinase, GTPase-activating protein (GAP), and GAP-associated proteins with the colony-stimulating factor 1 receptor. Mol. Cell. Biol. 1990, 10(11):5601-5608.
205. Reedijk M., Liu X., van der Geer P., et al. Tyr721 regulates specific binding of the CSF-1 receptor kinase insert to PI 3'-kinase SH2 domains: a model for SH2-mediated receptor-target interactions. Embo J. 1992, 11(4):1365-1372.
206. Reimann T., Büscher D., Hipskind R.A., et al. Lipopolysaccharide induces activation of the Raf-1/MAP kinase pathway. A putative role for Raf-1 in the induction of the IL-1 beta and the TNF-alpha genes. J. Immunol. 1994, 153(12):5740-5749.
207. Rettenmier C.W., Roussel M.F., Asmun R.A., et al. Synthesis of membrane-bound colony-stimulating factor 1 (CSF-1) and downmodulation of CSF-1 receptors in NIH 3T3 cells transformed by cotransfection of the human CSF-1 and c-fms (CSF-1 receptor) genes. Mol. Cell. Biol. 1987, 7(7):2378-2387.
208. Ridge S.A., Worwood M., Oscier D., et al. FMS mutations in myelodysplastic, leukemic, and normal subjects. Proc. Natl. Acad. Sci. USA 1990, 87(4):1377-1380.
209. Roche S., Koegl M., Courtneidge S.A. The phosphatidylinositol 3-kinase alpha is required for DNA synthesis induced by some, but not all, growth factors. Proc. Natl. Acad. Sci. USA 1994, 91(19):9185-9919.
210. Rock C.O., Cleveland J.L., Jackowski S. Macrophage growth arrest by cyclic AMP defines a distinct checkpoint in the mid-G1 stage of the cell cycle and overrides constitutive c-myc expression. Mol. Cell. Biol. 1992, 12(5):2351-2358.
211. Roilides E., Sein T., Holmes A., et al. Effects of macrophage colony-stimulating factor on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. J. Infect. Dis. 1995, 172:1028-1034.
212. Roussel E., Gerrard J.M., et al. Long-term cultures of human peripheral blood lymphocytes with recombinant human interleukin-2, generate a population of virtually pure CD3+ CD16- CD56- large granular lymphocyte LAK cells. Clin. Exp. Immunol. 1990, 82(2):416-421.
213. Roussel M.F., Sherr C.J. Mouse NIH 3T3 cells expressing human colony-stimulating factor 1 (CSF-1) receptors overgrow in serum-free medium containing human CSF-1 as their only growth factor. Proc. Natl. Acad. Sci. USA 1989, 86(20):7924-7927.
214. Roussel M.F., Cleveland J.L., Shurtleff S.A., Sherr C.J. Myc rescue of a mutant CSF-1 receptor impaired in mitogenic signaling. Nature 1991, 353(6342):361-363.
215. Roussel M.F., Davis J.N., Cleveland J.L., et al. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1. Oncogene 1994, 9(2):405-415.
216. Roussel M.F., Downing J.R., Rettenmier C.W., Sherr C.J. A point mutation in the extracellular domain of the human CSF-1 receptor (c-fms proto-oncogene product) activates its transforming potential. Cell 1988, 55(6):979-988.
217. Roussel M.F., Dull T.J., Rettenmier C.W., et al. Transforming potential of the c-fms proto-oncogene (CSF-1 receptor). Nature 1987, 325(6104):549-552.
218. Roussel M.F., Rettenmier C.W., Sherr C.J. Introduction of a human colony stimulating factor-1 gene into a mouse macrophage cell line induces CSF-1 independence but not tumorigenicity. Blood 1988, 71:1218-1225.
219. Roussel M.F., Shurtleff S.A., Downing J.R., Sherr C.J., et al. A point mutation at tyrosine-809 in the human colony-stimulating factor 1 receptor impairs mitogenesis without abrogating tyrosine kinase activity, association with phosphatidylinositol 3-kinase, or induction of c-fos and junB genes. Proc. Natl. Acad. Sci. USA 1990, 87(17):6738-6742.
220. Rovida E., Rigacci S., Paccagnini A., et al. The low-molecular-weight phosphotyrosine protein phosphatase, when overexpressed, reduces the mitogenic response to macrophage colony-stimulating factor and tyrosine phosphorylation of its receptor. Biochem. Biophys. Res. Commun. 1998, 253(2):300-304.
221. Saleem A., Kharbanda S., Yuan Z.-M., Kufe D., et al. Monocyte colony-stimulating factor stimulates binding of phosphatidylinositol 3-kinase to Grb2.Sos complexes in human monocytes. J. Biol. Chem. 1995, 270(18):10380-10383.
222. Saleh M.N., Khazaeli M.B., Wheeler R.H., et al. Phase II trial of murine monoclonal antibody D612 combined with recombinant human monocyte colony-stimulating factor (rhM-CSF) in patients with metastatic gastrointestinal cancer. Cancer Res. 1995, 55:4339-4346.
223. Sanda M.G., Bolton E., Mule J.J., Rosenberg S.A. In vivo administration of recombinant macrophage colony-stimulating factor induces macrophage-mediated antibody-dependent cytotoxicity of tumor cells. J. Immunother. 1992, 12:132-137.
224. Sanda M.G., Yang J.C., Topalian S.L., et al. Intravenous administration of recombinant human macrophage colony-stimulating factor to patients with metastatic cancer: a phase I study. J. Clin. Oncol. 1992, 10:1643-1649.
225. Santambrogio L., Belyanskaya S.L., Fischer F.R., et al. Developmental plasticity of CNS microglia. Proc. Natl. Acad. Sci. USA 2001, 98:6295-6300.
226. Schmid I., Baldwin G.C., Jacobs E.L., et al. Alterations in phenotype and cell-surface antigen expression levels of human monocytes: differential response to in vivo administration of rhM-CSF or rhGM-CSF. Cytometry 1995, 22:103-110.
227. Scholl S.M., Lidereau R., de la R.A., et al. Circulating levels of the macrophage colony stimulating factor CSF-1 in primary and metastatic breast cancer patients. A pilot study. Breast Cancer Res. Treat. 1996, 39:275-283.
228. Scholl S.M., Pallud C., Beuvon F., et al. Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis. J. Natl. Cancer. Inst. 1994, 86:120-126.
229. Scopes J., Massey H.M., Ebrahim H., et al. Interleukin-4 and interleukin-13: bidirectional effects on human osteoclast formation. Bone 2001, 29:203-208.
230. Sengupta A., Liu W.K., Yeung Y.G., et al. Identification and subcellular localization of proteins that are rapidly phosphorylated in tyrosine in response to colony-stimulating factor 1. Proc. Natl. Acad. Sci. USA 1988, 85(21):8062-8066.
231. Servet-Delprat C., Arnaud S., Jurdic P., et al. Flt3+ macrophage precursors commit sequentially to osteoclasts, dendritic cells and microglia. BMC. Immunol. 2002, 3:15.
232. Sester D.P., Naik S., Beasley S.J., et al. Phosphorothioate backbone modification modulates macrophage activation by CpG DNA. J. Immunol. 2000, 165(8):4165-4173.
233. Sevilla L., Aperlo C., Dulic V., et al. The Ets2 transcription factor inhibits apoptosis induced by colony-stimulating factor 1 deprivation of macrophages through a Bcl-xL-dependent mechanism. Mol. Cell. Biol. 1999, 19(4):2624-2634.
234. Shadle P.J., Allen J.I., Geier M.D., Koths K. Detection of endogenous macrophage colony-stimulating factor (M-CSF) in human blood. Exp. Hematol. 1989, 17:154-159.
235. Sherr C.J. The fms oncogene. Biochim. Biophys. Acta 1988, 948(2):225-243.
236. Sherr C.J. Mitogenic response to colony-stimulating factor 1. Trends Genet. 1991, 7(11-12):398-402.
237. Sherr C.J. Mammalian G1 cyclins. Cell 1993, 73(6):1059-1065.
238. Shieh J.H., Peterson R.H., Warren D.J., et al. Modulation of colony-stimulating factor-1 receptors on macrophages by tumor necrosis factor. J. Immunol. 1989, 143(8):2534-2539.
239. Shiotani A., Takami M., Itoh K., et al. Regulation of osteoclast differentiation and function by receptor activator of NFkB ligand and osteoprotegerin. Anat. Rec. 2002, 268:137-146.
240. Shultz L.D., Schweitzer P.A., Rajan T.V., et al. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 1993, 73(7):1445-1454.
241. Shurtleff S.A., Downing J.R., Rock C.O., et al. Structural features of the colony-stimulating factor 1 receptor that affect its association with phosphatidylinositol 3-kinase. Embo J. 1990, 9(8):2415-2421.
242. Si Q., Cosenza M., Zhao M.L., et al. GM-CSF and M-CSF modulate beta-chemokine and HIV-1 expression in microglia. GLIA 2002, 39:174-183.
243. Smith M.R., DeGudicibus S.J., Stacey D.W. Requirement for c-ras proteins during viral oncogene transformation. Nature 1986, 320(6062):540-543.
244. Soriano P., Montgomery C., Geske R., Bradley A. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 1991, 64(4):693-702.
245. Stanley E.R. The macrophage colony-stimulating factor, CSF-1. Methods Enzymol. 1985, 116:564-587.
246. Stanley E.R. Colony Stimulating Factor-1 (Macrophage Colony Stimulating Factor). Cytokine Handbook 1994, 387-418. Academic Press, London. A. Thomson (Ed.).
247. Stanley E.R., Berg K.L., Einstein D.G., et al. The biology and action of colony stimulating factor-1. Stem Cells 1994, 12(Suppl 1):15-24. discussion 25.
248. Stein J., Rettenmier C.W. Proteolytic processing of a plasma membrane-bound precursor to human macrophage colony-stimulating factor (CSF-1) is accelerated by phorbol ester. Oncogene 1991, 6:601-605.
249. Strassmann G., Bertolini D.R., Kerby S.B., Fong M. Regulation of murine mononuclear phagocyte inflammatory products by macrophage colony-stimulating factor. Lack of IL-1 and prostaglandin E2 production and generation of a specific IL-1 inhibitor. J. Immunol. 1991, 147(4):1279-1285.
250. Suzu S., Kimura F., Ota J., et al. Biologic activity of proteoglycan macrophage colony-stimulating factor. J. Immunol. 1997, 159:1860-1867.
251. Suzu S., Kimura F., Yamada M., et al. Directinteraction of proteoglycan macrophage colony-stimulating factor and basic fibroblast growth factor. Blood 1994, 83:3113-3119.
252. Suzu S., Ohtsuki T., Makishima M., et al. Biological activity of a proteoglycan form of macrophage colony-stimulating factor and its binding to type V collagen. J. Biol. Chem. 1992, 267:16812-16815.
253. Suzu S., Ohtsuki T., Yanai N., et al. Identification of a high molecular weight macrophage colony-stimulating factor as a glycosaminoglycan-containing species. J. Biol. Chem. 1992, 267:4345-4348.
254. Takahashi M., Hong Y.M., Yasuda S., et al. Macrophage colony-stimulating factor is produced by human T lymphoblastoid cell line, CEM-ON: identification by amino-terminal amino acid sequence analysis. Biochem. Biophys. Res. Commun. 1988, 152:1401-1409.
255. Takeshita S., Arai S., Kudo A. Identification and characterization of mouse bone marrow stromal cell, lines immortalized by temperature-sensitive SV40 T antigen: supportive activity for osteoclast differentiation. Bone 2001, 29:236-241.
256. Tanaka S., Neff L., Baron R., Levy J.B. Tyrosine phosphorylation and translocation of the c-cbl protein after activation of tyrosine kinase signaling pathways. J. Biol. Chem. 1995, 270(24):14347-14351.
257. Tapley P., Kazlauskas A., Cooper J.A., Rohrschneider L.R. Macrophage colony-stimulating factor-induced tyrosine phosphorylation of c-fms proteins expressed in FDC-P1 and BALB/c 3T3 cells. Mol. Cell. Biol. 1990, 10(6):2528-2538.
258. Taylor E.W., Fear A.L., Bohm A., et al. Structure-function studies on recombinant human macrophage colony-stimulating factor (M-CSF). J. Biol. Chem. 1994, 269:31171-31177.
259. Thery C., Hetier E., Evrard C., Mallat M. Expression of macrophage colony-stimulating factor gene in the mouse brain during development. J. Neurosci. Res. 1990, 26:129-133.
260. Timms J.F., Carlberg K., Gu H., et al. Identification of major binding proteins and substrates for the SH2-containing protein tyrosine phosphatase SHP-1 in macrophages. Mol. Cell. Biol. 1998, 18(7):3838-3850.
261. Tobal K., Pagliuca A., Bhatt B., et al. Mutation of the human FMS gene (M-CSF receptor) in myelodysplastic syndromes and acute myeloid leukemia. Leukemia 1990, 4(7):486-489.
262. Treisman R. Journey to the surface of the cell: Fos regulation and the SRE. Embo J. 1995, 14(20):4905-4913.
263. Trouliaris S., Smola U., Chang U.-H., et al. Tyrosine 807 of the v-Fms oncogene product controls cell morphology and association with p120RasGAP. J. Virol. 1995, 69(10):6010-6020.
264. Tuck D.P., Cerretti D.P., Hand A., et al. Human macrophage colony-stimulating factor is expressed at and shed from the cell surface. Blood 1994, 84:2182-2188.
265. Tushinski R.J., Stanley E.R. The regulation of mononuclear phagocyte entry into S phase by the colony stimulating factor CSF-1. J. Cell. Physiol. 1985, 122(2):221-228.
266. Uchimura T., Motomiya Y., Okamura H., et al. Marked increases in macrophage colony-stimulating factor and interleukin-18 in maintenance hemodialysis patients: comparative study of advanced glycation end products, carboxymethyllysine and pentosidine. Nephron 2002, 90:401-407.
267. Vadiveloo P.K., Vairo G., Novak U., et al. Differential regulation of cell cycle machinery by various antiproliferative agents is linked to macrophage arrest at distinct G1 checkpoints. Oncogene 1996, 13(3):599-608.
268. Vadiveloo P.K., Vairo G., Royston A.K., et al. Proliferation-independent induction of macrophage cyclin D2, and repression of cyclin D1, by lipopolysacharide. J. Biol. Chem. 1998, 273:23104-23109.
269. Vairo G., Hamilton J.A. Activation and proliferation signals in murine macrophages: stimulation of Na+ K+-ATPase activity by hemopoietic growth factors and other agents. J. Cell. Physiol. 1988, 134(1):13-24.
270. Vairo G., Hamilton J.A. Signaling through CSF receptors. Immunol. Today 1991, 12(10):362-369.
271. Vairo G., Argyriou S., Bordun A.-M., et al. Na+/H+ exchange involvement in colony-stimulating factor-1-stimulated macrophage proliferation. Evidence for a requirement during late G1 of the cell cycle but not for early growth factor responses. J. Biol. Chem. 1990, 265(28):16929-16939.
272. Vairo G., Argyriou S., Bordun A.-M., et al. Inhibition of the signaling pathways for macrophage proliferation by cyclic AMP. Lack of effect on early responses to colony stimulating factor-1. J. Biol. Chem. 1990, 265(5):2692-2701.
273. Vairo G., Argyriou S., Knight K.R., Hamilton J.A. Inhibition of colony-stimulating factor-stimulated macrophage proliferation by tumor necrosis factor-alpha, IFN-gamma, and lipopolysaccharide is not due to a general loss of responsiveness to growth factor. J. Immunol. 1991, 146(10):3469-3477.
274. Vairo G., Cocks B.G., Cragoe E.J., Hamilton J.A. Selective suppression of growth factor-induced cell cycle gene expression by Na+/H+ antiport inhibitors. J. Biol. Chem. 1992, 267(27):19043-19046.
275. Vairo G., Royston A.K., Hamilton J.A. Biochemical events accompanying macrophage activation and the inhibition of colony-stimulating factor-1-induced macrophage proliferation by tumor necrosis factor-alpha, interferon-gamma, and lipopolysaccharide. J. Cell. Physiol. 1992, 151(3):630-641.
276. Vairo G., Vadiveloo P.K., Royston A.K., et al. Deregulated c-myc expression overrides IFN gamma-induced macrophage growth arrest. Oncogene 1995, 10(10):1969-1976.
277. Valledor A.F., Comalada M., Xaus J., et al. The differential time-course of extracellular-regulated kinase activity correlates with the macrophage response toward, proliferation or activation. J. Biol. Chem. 2000, 275(10):7403-7409.
278. Valledor A.F., Xaus J., Marques L., et al. Macrophage colony-stimulating factor induces the expression of mitogen-activated protein kinase phosphatase-1 through a protein kinase C-dependent pathway. J. Immunol. 1999, 163(5):2452-2462.
279. van Daalen Wetters T., Hawkins S.A., Roussel M.F., Sherr C.J. Random mutagenesis of CSF-1 receptor (FMS) reveals multiple sites for activating mutations within the extracellular domain. Embo J. 1992, 11(2):551-557.
280. van de Wijngaert F.P., Tas M.C., Burger E.H. Conditioned medium of fetal mouse long bone rudiments stimulates the formation of osteoclast precursor-like cells from mouse bone marrow. Bone 1989, 10:61-68.
281. van der Geer P., Hunter T. Identification of tyrosine 706 in the kinase insert as the major colony-stimulating factor 1 (CSF-1)-stimulated autophosphorylation site in the CSF-1 receptor in a murine macrophage cell line. Mol. Cell. Biol. 1990, 10(6):2991-3002.
282. van der Geer P., Hunter T. Tyrosine 706 and 807 phosphorylation site mutants in the murine colonystimulating factor-1 receptor are unaffected in their ability to bind or phosphorylate phosphatidylinositol-3 kinase but show differential defects in their ability to induce early response gene transcription. Mol. Cell. Biol. 1991, 11(9):4698-4709.
283. van der Geer P., Hunter T. Mutation of Tyr697, a GRB2-binding site, and Tyr721, a PI 3-kinase binding site, abrogates signal transduction by the murine CSF-1 receptor expressed in Rat-2 fibroblasts. Embo J. 1993, 12(13):5161-5172.
284. Varticovski L., Druker B., Morrison D., et al. The colony stimulating factor-1 receptor associates with and activates phosphatidylinositol-3 kinase. Nature 1989, 342(6250):699-702.
285. Veis N., Hamilton J.A. GM-CSF and IL-3 stimulate diacylglycerol generation in murine bone marrow-derived macrophages. Biochem. Biophys. Res. Commun. 1991, 179(1):586-591.
286. Vincent V.A., Selwood S.P., Murphy G.M. Proinflammatory effects of M-CSF and A beta in hippocampal organotypic cultures. Neurobiol. Aging 2002, 23:349-362.
287. Vitt C.R., Fidler J.M., Ando D., et al. Antifungal activity of recombinant human macrophage colony-stimulating factor in models of acute and chronic candidiasis in the rat. J. Infect. Dis. 1994, 169:369-374.
288. Wang Y., Yeung Y.G., Langdon W.Y., et al. c-Cbl is transiently tyrosine-phosphorylated, ubiquitinated, and membrane-targeted following CSF-1 stimulation of macrophages. J. Biol. Chem. 1996, 271(1):17-20.
289. Wang Z.E., Myles G.M., Brandt C.S., et al. Identification of the ligand-binding regions in the macrophage colony-stimulating factor receptor extracellular domain. Mol. Cell. Biol. 1993, 13(9):5348-5359.
290. Wang Y., Yeung Y.G., Stanley E.R. CSF-1 stimulated multiubiquitination of the CSF-1 receptor and of Cbl follows their tyrosine phosphorylation and association with other signaling proteins. J. Cell. Biochem. 1999, 72(1):119-134.
291. Welham M.J., Duronio V., Leslie K.B., et al. Multiple hemopoietins, with the exception of interleukin-4, induce modification of Shc and mSos1, but not their translocation. J. Biol. Chem. 1994, 269(33):21165-21176.
292. Werner K., Bitsch A., Bunkowski S., et al. The relative number of macrophages/microglia expressing macrophage colony-stimulating factor and its receptor decreases in multiple sclerosis lesions. GLIA 2002, 40:121-129.
293. Whetton A.D., Monk P.N., Consalvey S.D., Downes C.P. The haemopoietic growth factors interleukin 3 and colony stimulating factor-1 stimulate proliferation but do not induce inositol lipid breakdown in murine bone-marrow-derived macrophages. Embo J. 1986, 5(12):3281-3286.
294. Wiktor-Jedrzejczak W., Bartocci A., Ferrante A.W., et al. Total absence of colony-stimulating factor 1 in the macrophage- deficient osteopetrotic (op/op) mouse. Proc. Natl. Acad. Sci. USA 1990, 87(12):4828-4832. [published erratum appears in Proc. Natl. Acad. Sci. USA (1991) 88 (13): 5937].
295. Wilhelmsen K., Burkhalter S., van der Geer P. C-Cbl binds the CSF-1 receptor at tyrosine 973, a novel phosphorylation site in the receptor's carboxy-terminus. Oncogene 2002, 21(7):1079-1089.
296. Williamson E., Bilsborough J.M., Viney J.L. Regulation of mucosal dendritic cell function by receptor activation of NF-kappaB (RANK)/RANK ligand interactions: impact on tolerance induction. J. Immunol. 2002, 169(7):3606-3612.
297. Wilson N.J., Jaworowski A., Ward A.C., et al. cAMP enhances CSF-1-induced ERK activity and c-fos mRNA expression via a MEK-dependent and Ras-independent mechanism in macrophages. Biochem. Biophys. Res. Commun. 1998, 244(2):475-480.
298. Wong B.R., Josien R., Lee S.Y., et al. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J. Exp. Med. 1997, 186:2075-2080.
299. Woolford J., McAuliffe A., Rohrschneider L.R. Activation of the feline c-fms proto-oncogene: multiple alterations are required to generate a fully transformed phenotype. Cell 1988, 55(6):965-977.
300. Xie Y., von Gavel S., Cassady A.I., et al. The resistance of macrophage-like tumour cell lines to growth inhibition by lipopolysaccharide and pertussis toxin. Br. J. Haematol. 1993, 84(3):392-401.
301. Xu J., Kim S., Chen M., et al. Blockage of the early events of mitogenic signaling by interferon-gamma in macrophages in response to colony-stimulating factor-1. Blood 1995, 86(7):2774-2788.
302. Xu X.X., Rock C.O., Qiu Z.-H., et al. Regulation of cytosolic phospholipase A2 phosphorylation and eicosanoid production by colony-stimulating factor 1. J. Biol. Chem. 1994, 269(50):31693-31700.
303. Xu X.X., Tessner T.G., Rock C.O., Jackowski S. Phosphatidylcholine hydrolysis and c-myc expression are in collaborating mitogenic pathways activated by colony-stimulating factor 1. Mol. Cell. Biol. 1993, 13(3):1522-1533.
304. Yamada T., Yamazaki H., Yamane T., et al. Regulation of osteoclast development by Notch signaling directed to osteoclast precursors and through stromal cells. Blood 2002, prepublished online 31/10/2002.
305. Yamada Y., Ohmoto Y., Yamamura M., et al. Plasma M-CSF as an indicator of response to chemotherapy in adult T cell leukemia patients. Leuk. Lymphoma 1996, 22:457-461.
306. Yeung Y.G., Berg K.L., Pixley F.J., et al. Protein tyrosine phosphatase-1C is rapidly phosphorylated in tyrosine in macrophages in response to colony stimulating factor-1. J. Biol. Chem. 1992, 267(33):23447-23450.
307. Yeung Y.G., Soldera S., Stanley E.R. A novel macrophage actin-associated protein (MAYP) is tyrosine-phosphorylated following colony stimulating factor-1 stimulation. J. Biol. Chem. 1998, 273(46):30638-30642.
308. Yi T., Mui A.L., Krystal G., Ihle J.H. Hematopoietic cell phosphatase associates with the interleukin-3 (IL-3) receptor beta chain and down-regulates IL-3-induced tyrosine phosphorylation and mitogenesis. Mol. Cell. Biol. 1993, 13(12):7577-7586.
309. Yokoyama M., Suto Y., Sato H., et al. Low serum lipids suggest severe bone marrow failure in children with aplastic anemia. Pediatr. Int. 2000, 42:613-619.
310. Yoshida H., Hayashi S., Kunisada I., et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 1990, 345(6274):442-444.
311. Yusoff P., Hamilton J.A., Nolan R.D., et al. Haematopoietic colony stimulating factors CSF-1 and GM-CSF increase phosphatidylinositol 3-kinase activity in murine bone marrow-derived macrophages. Growth Factors 1994, 10(3):181-192.
312. Zisman E., Waisman A., Ben Yair E., Tartakovsky B. Production of colony-stimulating factor 1 by T cells: possible involvement in their interaction with antigen-presenting cells. Cytokine 1993, 5:309-318.